Evidence map›Paper›PMID 28527051›Full record

ReviewNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2017

New treatments for headache.

Kasra Maasumi, Stewart J Tepper, Alan M Rapoport

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2018
    Article
  2. A new era in headache treatment.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2018
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kasra MaasumiNeurology, Headache, University of California San Francisco (UCSF), 2330 Post Street Unit 610, San Francisco, CA, 94115, USA. Kmaasumi@gmail.com.
Stewart J TepperThe Giesel School of Medicine at Dartmouth, Hanover, NH, USA.
Alan M RapoportUniversity of California Los Angeles, Los Angeles, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Headache disorders are common worldwide and often disabling. Until recently, treatments were borrowed from other branches of neurology and medicine. Monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) ligand and receptor, small molecule CGRP receptor antagonist gepants, serotonin

Indexed as

Antibodies, MonoclonalCalcitonin Gene-Related PeptideHeadache DisordersHumansNeurotransmitter AgentsPiperidinesPyridinesSerotonin Receptor AgonistsTreatment OutcomeAntibodies, MonoclonalCALCA protein, humanCalcitonin Gene-Related PeptideNeurotransmitter AgentsPiperidinesPyridinesrimegepant sulfateSerotonin Receptor AgonistsCalcitonin gene-related peptide (CGRP)Headache treatmentMagnetic stimulationMonoclonal antibodiesNeuromodulationNeurostimulation

Identifiers

PMID28527051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.